IndiaTickerAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Company dossier
Ajanta Pharma
NSE:AJANTPHARM · ISIN INE031B01049
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Ajanta Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Copy of Newspaper Publication - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Ajanta Pharma Ltd - 532331 - Results For 30.06.2026BSE · financial results · pdf
Source filing Ajanta Pharma Ltd - 532331 - Board Meeting Outcome for BM OutcomeBSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Record Date Intimation For DividendBSE · corporate action · pdf
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · pdf
Source filing Ajanta Pharma Ltd - 532331 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Ajanta Pharma LimitedNSE · conference call · pdf
Source filing General Updates - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Ajanta Pharma LimitedNSE · financial results · pdf
Archived filing Dividend - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Record Date - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Ajanta Pharma LimitedNSE · conference call · pdf
Source filing Ajanta Pharma Ltd - 532331 - Board Meeting Intimation for Board Meeting Scheduled To Be Held On 30Th July 2026.BSE · financial results · pdf
Source filing Ajanta Pharma Ltd - 532331 - Update on board meetingBSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Ajanta Pharma LimitedNSE · conference call · pdf
Source filing Ajanta Pharma Ltd - 532331 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Shareholders meeting - Ajanta Pharma LimitedNSE · exchange filing · pdf
Archived filing Ajanta Pharma Ltd - 532331 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Shareholders meeting - Ajanta Pharma LimitedNSE · exchange filing · pdf
Archived filing Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Ajanta Pharma Ltd - 532331 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing General Updates - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Update On US FDA Inspection At Paithan Manufacturing FacilityBSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing Trading Window - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Ajanta Pharma LimitedNSE · exchange filing · pdf
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing